Clinical trial · Interventional
The ROAD 2.0 to Sustainable Medication Use: Redispensing Unused Oral Anticancer Drugs
Cost-savings and Environmental Impact Obtained From Redispensing Unused Oral Anticancer Drugs
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this prospective intervention study is to investigate the effectiveness of redispensing unused oral anticancer drugs. The main questions it aims to answer are: * What are the cost-savings of redispensing unused oral anticancer drugs? * What is the environmental impact of redispensing unused oral anticancer drugs? Researchers will compare redispensing unused oral anticancer drugs to the standard practice of disposal. Participants will receive their oral anticancer drugs in a sealed bag with a temperature indicator if needed. They will be asked to return any unused oral anticancer drugs to the pharmacy during their next visit to the hospital.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Drug Prescriptions | — | UNRESOLVED | — |
| Oncology | — | UNRESOLVED | — |
| Pharmacy | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| redispensing oral anticancer drugs | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- Intervention
- interventionNames
- Other: redispensing oral anticancer drugs
Primary outcomes (2)
- measure
- The environmental impact of redispensing unused oral anticancer drugs of verified quality compared to standard practice of disposal.
- timeFrame
- From date of first dispensing unit the date of last unused medication package returning to the pharmacy, assessed up to 16 months
- description
- Environmental impact will be measured in CO2-eq
- measure
- Cost-savings obtained by redispensing unused oral anticancer drugs of verified quality compared to standard practice of disposal.
- timeFrame
- From date of first dispensing unit the date of last unused medication package returning to the pharmacy, assessed up to 16 months.
- description
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Patients of all ages * A clinical diagnosis of cancer using an oral anticancer drug that requires storage at room temperature according to the Summary of Product Characteristics (SmPC). Exclusion Criteria: * Patients that do not understand the Dutch or English language, in written or spoken. * Patients receiving prescriptions that contain an amount of tablets that deviates from the regular package size, resulting in the pharmacy dispensing an opened package
References
Publications (0)
Data not yet available